Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Monday, January 16, 2017
Louisiana Board of Pharmacy Regulatory Proposals
2016-H ~ Amends Chapter 27 - Controlled Dangerous Substances to streamline the reinstatement process for prescribing practitioners whose primary professional licenses were suspended or revoked by their primary professional licensing agency. 11-16-2016 - Board voted to approve Draft #1 for promulgation, and further, voted to approve the Declaration of Emergency and set the effective date for the Emergency Rule as November 17, 2016. 01-20-2017 - Incorporated as Regulatory Project 2016-5.
2016-G ~ Amends Chapter 25 - Prescriptions, Drugs and Devices to create a new section §2514 - Standing Orders for the Distribution of Naloxone and Other Opioid Antagonists. Authorized by Act 370 of the 2016 Legislature, the new rule allows pharmacists to distribute naloxone or other opioid antagonists pursuant to nonpatient-specific standing orders issued by licensed medical practitioners. 08-10-2016 - Board voted to approve Draft #1 for promulgation, and further, voted to approve the Declaration of Emergency and set the effective date for the Emergency Rule as August 10, 2016. 12-07-2016 - Board re-issued Emergency Rule, effective today 01-20-2017 - Incorporated as Regulatory Project 2016-4.